Dr Mitchell (Reference Mitchell2006) suggests that it may be pertinent to re-examine another commonly quoted recommendation - that an antidepressant trial must be at least 6 to 8 weeks before switching drugs. The evidence on which switch guidelines are based is weak but these guidelines are applied frequently in daily clinical practice. In previous studies symptom improvement at earlier time points in relation to response has been investigated (e.g. Reference Koran, Hamilton and HertzmarKoran et al, 1995) but the ultimate goal of depression treatment is complete remission. Remission takes longer than 4-6 weeks to achieve but substantial improvement is unlikely after 10-12 weeks (Reference Trivedi, Rush and WisniewskiTrivedi et al, 2006). Quitkin et al (Reference Quitkin, Petkova and McGrath2003) investigated the relationship between initial change in symptoms and remission by week 12 and demonstrated that even when there was no improvement after 6 weeks of treatment, an antidepressant trial should be continued because the proportion of patients attaining remission by week 12 was still considerable (i.e. greater than 30%). They argued that a switch of antidepressant medication would be unlikely to have resulted in higher remission rates. Furthermore, large studies are required in which change in symptoms is frequently measured at uniform time-points and dimensions other than those measured by conventional questionnaires for depression are assessed. These might be more sensitive to early change following the initiation of antidepressant treatment (Reference Harmer, Shelley and CowenHarmer et al, 2004), and therefore might better predict which patients will attain remission. Calculation of the sensitivity, specificity, area under the receiver operating characteristic curve, and positive and negative predictive power to assess the likelihood of remission for various levels of symptom change at different time-points would help clinicians to decide on clinical applicability. Results from such studies will improve the evidence on which switch guidelines are based.
No CrossRef data available.
eLetters
No eLetters have been published for this article.